Written by MARI YAMAGUCHI

Japan suspended use of about 1.63 million doses of Moderna vaccine Thursday after contamination was found in unused vials, raising concern of a supply shortage as the country tries to accelerate vaccinations amid a COVID-19 surge.

The health ministry said contamination was reported from multiple vaccination sites. Some doses might have been administered, but no adverse health effects have been reported so far, officials said.

Takeda Pharmaceutical Co., a Japanese drugmaker in charge of sales and distribution of the vaccine in Japan, said it decided to suspend use of doses manufactured in the same production line as a safety precaution.

It asked Moderna to conduct an emergency investigation and told medical institutions and organizers to stop using the vaccine produced in Spain and shared the production numbers that may be affected.

The health ministry and Takeda did not give details on the type of contamination or if the doses in question may have been distributed outside Japan.

The Moderna vaccine problem came just as Japan struggles with surging infections, with daily new cases hitting new highs in many parts of the country and severely straining the health care system.

Chief Cabinet Secretary Katsunobu Kato told reporters the government and Takeda are discussing ways to minimize the impact on Japan’s vaccination progress.

“We will do utmost in order to avoid any impact on vaccination progress, especially at worksites and large-scale centers,” Kato said.

Japan relies entirely on foreign-developed vaccines by Moderna, as well as Pfizer Inc. and AstraZeneca. Moderna has been since mid-June at large-scale centers and workplace inoculations and has helped speed up Japan’s rollout.

About 43% of the Japanese population have been fully vaccinated, with daily doses of about 1 million.

 

Related Stories
‹
US Clears Updated COVID Boosters Targeting Newest Variants
Written by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
Marathon US Hearings To Decide Fate of COVID Shots for Tots
Written by LAURAN NEERGAARD Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week. On Wednesday, both Moderna and Pfizer will have to convince what’s essentially a science court — advisers to the Food and Drug Administration — that their shots work well in babies, toddlers and […]
Next on FDA’s Agenda: Booster Shots of Moderna, J&J Vaccines
Written by LAURAN NEERGAARD and MATTHEW PERRONE With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn. Federal regulators begin tackling that question this week. On Thursday and Friday, […]
Medically At-Risk North Carolinians Can Get Third COVID Shot
Written by BRYAN ANDERSON North Carolina health officials said Monday that medically vulnerable residents with certain health conditions can get an additional dose of COVID-19 vaccine, though some have already had a third Pfizer or Moderna shot after the U.S. Food and Drug Administration approved it last week. The FDA signed off on the additional dose after […]
Is Japan’s Remarkable Vaccine Drive in Time for Olympics?
Written by MARI YAMAGUCHI After months of frustration and delay, Japan has hit the remarkable benchmark of 1 million vaccines a day. But with the Olympics set to start in less than a month, and only a small portion of the country vaccinated, a question lingers: Is it enough? The vaccination pace is quickening even […]
Pfizer COVID-19 Shot Expanded to U.S. Children as Young as 12
Written by LAURAN NEERGAARD and CANDICE CHOI U.S. regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12, offering a way to protect the nation’s adolescents before they head back to school in the fall and paving the way for them to return to more normal activities. Shots could begin […]
Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine
Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]
National Expert: Getting Kids Vaccinated Before School is 'Best Thing to Do'
Younger children are the age demographic that had the longest waits for COVID-19 vaccines to be approved. So far, their vaccination rates reflect that gap of time, but urgency around getting those initial doses has slowed to a crawl. With a new school year being just around the corner, though, federal health officials are saying […]
Officials: Millions of COVID-19 Shots Ordered for Youngest
Millions of COVID-19 vaccine doses have been ordered for small children in anticipation of possible federal authorization next week, White House officials say.
Moderna Seeks To Be 1st With COVID Shots for Littlest Kids
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
›